SLS

SELLAS Life Sciences is a biotech company developing experimental cancer treatments. Its main drug candidate, galinpepimut-S, is a type of immunotherapy that trains the immune system to attack cancer cells. The company is also working on a drug called tambiciclib that blocks a protein involved in cancer cell growth. SELLAS is testing these drugs in clinical trials, including a partnership with Merck to combine their lead drug with an existing cancer medication.